Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients

by Kamel Amraoui, Karim Belhadj, Bernard Maître, Caroline Jannière-Nartey, Jehan Dupuis
Published 2013-03-01

A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab

by Joseph Mikhael, Karim Belhadj-Merzoug, Cyrille Hulin, Laure Vincent, Philippe Moreau, Cristina Gasparetto, Ludek Pour, Ivan Spicka, Ravi Vij, Jeffrey Zonder, Djordje Atanackovic, Nashat Gabrail, Thomas G. Martin, Aurore Perrot, Samira Bensfia, Qilong Weng, Claire Brillac, Dorothée Semiond, Sandrine Macé, Kathryn P. Corzo, Xavier Leleu
Published 2021-05-01